CCND1 and central nervous system cancer: Chen et al [8] conducted a case- control study for Chinese population and suggested that the CCND1 G870A polymorphism modulated oncogenic cyclin D1b expression in glioma tissues and may be associated with an increased risk of gliomas in Chinese population.